Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke® celebrates 100 million ProcedurePak® trays - advancing operating room efficiency worldwide
Gothenburg, Sweden. 27 January 2026. Mölnlycke Health Care, a global leader in Medtech, headquarted in Gothenburg, Sweden, is celebrating the production of 100 million ProcedurePak® trays at the company's production sites in the Czech Republic.
This achievement reflects Mölnlycke’s commitment to more efficient and sustainable surgical care. With 100 million trays delivered, Mölnlycke has facilitated millions of procedures across the world, helping hospitals improve operating room workflows and consistency. Customised ProcedurePak trays can reduce surgical preparation time by up to 40%¹, giving healthcare teams more time to focus on patients and supporting smoother, more predictable operations.
“Reaching 100 million trays is far more than a production milestone. It represents a meaningful contribution to many millions of procedures in operating rooms worldwide. We are incredibly proud of the role we play in supporting healthcare systems and improving patient outcomes every single day,” says Fredrik Wallefors, Executive Vice President, Operating Room Solutions, Mölnlycke Health Care.
Mölnlycke’s customised ProcedurePak trays are assembled to contain all the single-use components required for a particular surgical intervention, replacing numerous individually packaged items. This tailored approach helps generate significant savings in time, cost and waste2 across both major and minor procedures.
For more information, please contact:
-
References
- Greiling M. A multinational case study to evaluate and quantify time-saving by using custom procedure trays for operating room efficiency. Poster presentation at the 23rd Congress of EAHM, Zürich, Switzerland, 9-10 Sep 2010.
- Assessing the carbon and waste benefits of moving to Procedure Packs at Royal Liverpool and Broadgreen University Hospitals, NHS Trust, 2011.
Latest news
-
Mölnlycke and AROA partner to expand access to Endoform in the US
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
-
Martin Ma joins Mölnlycke Zhende as General Manager
In this role, Martin will lead the joint venture's operations and growth strategy in China, with responsibility for commercial execution, organisational leadership, governance and delivery of growth ambitions in one of the world's largest wound care markets.
-
Mölnlycke launches MyFit™ by Biogel® to bring more inclusive sizing to surgical gloves
-
Mölnlycke joins ALPS as Gold Strategic Partner to advance limb preservation
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
-
New consensus document highlights need to address post-operative blistering to improve patient outcomes
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.
-
From pressure to potential: new report reveals opportunity to increase healthcare capacity
Gothenburg, Sweden. 21 September 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces the launch of The Hidden Capacity Report, a new international report revealing significant opportunities to expand day surgery and help healthcare systems improve efficiency, increase surgical throughput and enhance patient outcomes.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
-
Major Scottish Hospital Adopts Steriwave®
UK’s Largest Hip and Knee Replacement Centre Becomes First in Scotland to Adopt Steriwave® Nasal Photodisinfection.
-
5 million and growing: scaling Granudacyn® production in Salzburg